BACKGROUND: Breast cancer 1, early onset (BRCA1) is a vital DNA repair gene, and the single nucleotide polymorphisms (SNPs) of this gene have been studied in diverse cancer types. In this study, we investigated the association between eight common BRCA1 functional SNPs and the risk of differentiated thyroid carcinoma (DTC). METHODS: This cancer center-based case-control study included 303 DTC cases and 511 controls. A polymerase chain reaction-based restriction fragment length polymorphism assay was performed for genotyping. Unconditional logistical regression analysis was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) in single-SNP analysis and haplotype analysis. RESULTS: A decreased risk of DTC was found for the A1988G heterozygous AG genotype (adjusted OR=0.63, 95% CI: 0.45-0.87, Bonferroni-adjusted p-value=0.036). AATAATA and ATAA haplotypes that carry C33420T variant allele were associated with reduced papillary thyroid cancer risk (adjusted OR=0.52, 95% CI: 0.33-0.84; adjusted OR=0.62, 95% CI: 0.40-0.95, respectively). Also, having a combination of ≥3 favorable genotypes was associated with a DTC risk reduction (adjusted OR=0.69, 95% CI: 0.50-0.95). The A31875G AG/GG genotype was associated with a 69% reduced risk of multifocal primary tumor in DTC patients (adjusted OR=0.31, 95% CI: 0.12-0.81). CONCLUSION: BRCA1 genetic polymorphisms may play a role in DTC risk, while the possible associations warrant confirmation in independent studies.
BACKGROUND:Breast cancer 1, early onset (BRCA1) is a vital DNA repair gene, and the single nucleotide polymorphisms (SNPs) of this gene have been studied in diverse cancer types. In this study, we investigated the association between eight common BRCA1 functional SNPs and the risk of differentiated thyroid carcinoma (DTC). METHODS: This cancer center-based case-control study included 303 DTC cases and 511 controls. A polymerase chain reaction-based restriction fragment length polymorphism assay was performed for genotyping. Unconditional logistical regression analysis was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) in single-SNP analysis and haplotype analysis. RESULTS: A decreased risk of DTC was found for the A1988G heterozygous AG genotype (adjusted OR=0.63, 95% CI: 0.45-0.87, Bonferroni-adjusted p-value=0.036). AATAATA and ATAA haplotypes that carry C33420T variant allele were associated with reduced papillary thyroid cancer risk (adjusted OR=0.52, 95% CI: 0.33-0.84; adjusted OR=0.62, 95% CI: 0.40-0.95, respectively). Also, having a combination of ≥3 favorable genotypes was associated with a DTC risk reduction (adjusted OR=0.69, 95% CI: 0.50-0.95). The A31875G AG/GG genotype was associated with a 69% reduced risk of multifocal primary tumor in DTCpatients (adjusted OR=0.31, 95% CI: 0.12-0.81). CONCLUSION:BRCA1 genetic polymorphisms may play a role in DTC risk, while the possible associations warrant confirmation in independent studies.
Authors: Elizabeth G Grubbs; Thereasa A Rich; Guojun Li; Erich M Sturgis; Maher N Younes; Jeffrey N Myers; Beth Edeiken-Monroe; Bruno D Fornage; Douglas P Monroe; Gregg A Staerkel; Michelle D Williams; Steven G Waguespack; Mimi I Hu; Gilbert Cote; Robert F Gagel; James Cohen; Randal S Weber; Daniel A Anaya; F Chris Holsinger; Nancy D Perrier; Gary L Clayman; Douglas B Evans Journal: Curr Probl Surg Date: 2008-03 Impact factor: 1.909
Authors: Mary E Sehl; Lucy R Langer; Jeanette C Papp; Lorna Kwan; Joyce L Seldon; Geovanni Arellano; Jean Reiss; Elaine F Reed; Sugandha Dandekar; Yael Korin; Janet S Sinsheimer; Zuo-Feng Zhang; Patricia A Ganz Journal: Clin Cancer Res Date: 2009-03-10 Impact factor: 12.531
Authors: Jeffrey S Chang; Ru-Fang Yeh; John K Wiencke; Joseph L Wiemels; Ivan Smirnov; Alexander R Pico; Tarik Tihan; Joe Patoka; Rei Miike; Jennette D Sison; Terri Rice; Margaret R Wrensch Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-06 Impact factor: 4.254
Authors: Bernice R Packer; Meredith Yeager; Laura Burdett; Robert Welch; Michael Beerman; Liqun Qi; Hugues Sicotte; Brian Staats; Mekhala Acharya; Andrew Crenshaw; Andrew Eckert; Vinita Puri; Daniela S Gerhard; Stephen J Chanock Journal: Nucleic Acids Res Date: 2006-01-01 Impact factor: 16.971
Authors: Li Xu; Elaine Cristina Morari; Qingyi Wei; Erich M Sturgis; Laura S Ward Journal: J Clin Endocrinol Metab Date: 2012-03-21 Impact factor: 5.958
Authors: Anna Wójcicka; Małgorzata Czetwertyńska; Michał Świerniak; Joanna Długosińska; Monika Maciąg; Agnieszka Czajka; Kinga Dymecka; Anna Kubiak; Adam Kot; Rafał Płoski; Albert de la Chapelle; Krystian Jażdżewski Journal: Genes Chromosomes Cancer Date: 2014-03-06 Impact factor: 5.006
Authors: Luís S Santos; Susana N Silva; Octávia M Gil; Teresa C Ferreira; Edward Limbert; José Rueff Journal: Oncol Lett Date: 2018-02-21 Impact factor: 2.967